Update: 28.03.2023
Last week: 11 week 2023 (13.03.2023 - 19.03.2023)
Last full month: February 2023
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 101 190 | -3.0% | 2.7% | -0.3 | 25 758 594 | -5.4% | 3.1% | -0.4 | 8.4% |
| MoM | 412 232 | -20.9% | 2.7% | -0.1 | 112 037 618 | -20.3% | 3.4% | -0.1 | -18.0% |
| YTD | 1 191 172 | -68.8% | 2.8% | -3.3 | 319 536 856 | -57.0% | 3.4% | -2.5 | -31.7% |
| MAT | 7 215 286 | -52.3% | 3.9% | -2.7 | 1 596 602 044 | -40.9% | 4.0% | -2.1 | -18.7% |
| DEXALGIN | |||||||||
| WoW | 18 116 | 19.0% | 0.3% | 0 | 9 547 889 | 18.4% | 1.1% | 0 | 14.8% |
| MoM | 60 185 | -30.1% | 0.3% | -0.1 | 33 026 896 | -27.6% | 1.1% | -0.3 | -12.8% |
| YTD | 187 940 | -65.7% | 0.4% | -0.4 | 100 853 956 | -54.2% | 1.2% | -0.9 | -25.4% |
| MAT | 1 225 604 | -39.3% | 0.5% | -0.2 | 567 399 380 | -27.4% | 1.5% | -0.5 | -12.7% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 63 529 | 21.3% | 40.8% | -1.3 | 39 541 400 | 19.3% | 50.3% | -1 | 25.1% |
| MoM | 202 093 | -11.2% | 38.5% | -1 | 128 123 690 | -13.1% | 48.2% | -2.3 | -8.8% |
| YTD | 577 187 | -59.0% | 39.5% | -21 | 368 577 477 | -46.9% | 49.6% | -17.1 | -37.2% |
| MAT | 3 452 483 | -37.5% | 48.1% | -15.7 | 1 883 085 000 | -27.9% | 54.6% | -14.4 | -17.1% |
| ESPUMISAN BABY | |||||||||
| WoW | 22 566 | 10.1% | 29.7% | 1 | 17 329 175 | 9.0% | 46.2% | 1 | 6.4% |
| MoM | 80 707 | -9.9% | 29.3% | -0.3 | 63 130 353 | -9.6% | 46.6% | -0.1 | -8.9% |
| YTD | 225 524 | -44.5% | 29.4% | -10.4 | 175 717 237 | -27.8% | 46.4% | -7.7 | -24.8% |
| MAT | 1 245 016 | -25.7% | 34.5% | -6.2 | 837 799 842 | -15.3% | 48.5% | -6.7 | -12.4% |
| FASTUM | |||||||||
| WoW | 15 789 | 13.9% | 0.8% | 0 | 9 482 541 | 13.6% | 2.1% | -0.1 | 19.8% |
| MoM | 53 314 | -21.9% | 0.8% | -0.1 | 32 316 268 | -23.0% | 2.2% | -0.4 | -9.2% |
| YTD | 159 435 | -51.3% | 0.9% | -0.6 | 97 103 549 | -39.3% | 2.3% | -0.7 | -18.5% |
| MAT | 872 542 | -36.9% | 1.0% | -0.5 | 483 437 310 | -25.7% | 2.3% | -0.7 | -6.5% |
| IODOMARIN | |||||||||
| WoW | 84 912 | 23.9% | 23.7% | 0.9 | 15 687 818 | 21.9% | 9.9% | 0.6 | 19.3% |
| MoM | 263 479 | 2.2% | 22.3% | 1.5 | 49 430 699 | 3.6% | 9.0% | 1 | -4.5% |
| YTD | 719 400 | -17.1% | 22.0% | 1.2 | 134 104 656 | -19.4% | 8.8% | -0.2 | -21.5% |
| MAT | 3 144 759 | -8.2% | 20.8% | -0.4 | 607 635 557 | -5.7% | 9.0% | -0.4 | -6.5% |
| LIOTON | |||||||||
| WoW | 18 388 | 21.7% | 1.6% | 0 | 23 305 660 | 21.7% | 4.0% | 0 | 21.6% |
| MoM | 65 231 | 8.9% | 1.8% | 0.2 | 81 963 965 | 10.6% | 4.7% | 0.7 | -5.6% |
| YTD | 167 485 | -55.6% | 1.6% | -1 | 210 024 929 | -41.8% | 4.3% | -1.1 | -27.7% |
| MAT | 1 041 910 | -40.8% | 2.0% | -0.8 | 1 156 763 151 | -23.8% | 4.4% | -1.3 | -15.7% |
| MEZYM | |||||||||
| WoW | 236 762 | 10.2% | 18.1% | -1.6 | 37 797 962 | 11.7% | 12.8% | -0.6 | 20.0% |
| MoM | 800 140 | -20.3% | 19.4% | -0.2 | 126 219 061 | -19.0% | 13.0% | -0.4 | -19.5% |
| YTD | 2 364 240 | -60.6% | 19.3% | -11.8 | 371 278 883 | -58.9% | 13.1% | -9.3 | -36.4% |
| MAT | 13 718 553 | -38.8% | 22.4% | -7.6 | 2 112 068 919 | -34.1% | 15.8% | -6.4 | -17.9% |
| MIG 400 | |||||||||
| WoW | 133 316 | 21.2% | 2.5% | 0.1 | 15 623 973 | 21.6% | 1.8% | 0.1 | 14.8% |
| MoM | 394 153 | -20.0% | 2.1% | -0.2 | 46 693 631 | -25.9% | 1.6% | -0.3 | -12.8% |
| YTD | 1 189 145 | -49.1% | 2.3% | -1.1 | 144 627 104 | -46.4% | 1.8% | -0.9 | -25.4% |
| MAT | 7 251 052 | -31.3% | 3.0% | -0.8 | 868 768 573 | -27.4% | 2.2% | -0.8 | -12.7% |
| PROSTAMOL | |||||||||
| WoW | 24 169 | 17.1% | 13.0% | 0 | 36 314 700 | 17.5% | 14.5% | 0 | 17.3% |
| MoM | 80 544 | -12.7% | 12.9% | -0.9 | 122 384 313 | -11.5% | 14.6% | -1 | -6.3% |
| YTD | 230 107 | -57.2% | 13.3% | -9.6 | 347 024 342 | -53.2% | 14.9% | -9.4 | -26.3% |
| MAT | 1 239 131 | -43.0% | 15.7% | -8.5 | 1 770 132 936 | -37.2% | 16.8% | -9.1 | -12.2% |
| RESPERO MYRTOL | |||||||||
| WoW | 23 538 | 10.1% | 6.7% | -0.2 | 13 204 734 | 8.6% | 7.6% | -0.4 | 13.1% |
| MoM | 94 189 | -9.2% | 7.0% | -0.2 | 54 780 622 | -6.8% | 8.4% | -0.1 | -6.3% |
| YTD | 255 546 | -43.4% | 7.0% | -3.1 | 146 376 852 | -28.5% | 8.3% | -1.6 | -18.9% |
| MAT | 1 105 629 | -2.5% | 7.5% | 0.3 | 565 238 287 | 9.1% | 8.0% | 0.7 | -5.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 1 191 172 | -68.8% | 2.8% | -3.3 | 319 536 856 | -57.0% | 3.4% | -2.5 | -31.7% |
| DEXALGIN | 187 940 | -65.7% | 0.4% | -0.4 | 100 853 956 | -54.2% | 1.2% | -0.9 | -25.4% |
| ESPUMISAN (ADULTS) | 577 187 | -59.0% | 39.5% | -21 | 368 577 477 | -46.9% | 49.6% | -17.1 | -37.2% |
| ESPUMISAN BABY | 225 524 | -44.5% | 29.4% | -10.4 | 175 717 237 | -27.8% | 46.4% | -7.7 | -24.8% |
| FASTUM | 159 435 | -51.3% | 0.9% | -0.6 | 97 103 549 | -39.3% | 2.3% | -0.7 | -18.5% |
| IODOMARIN | 719 400 | -17.1% | 22.0% | 1.2 | 134 104 656 | -19.4% | 8.8% | -0.2 | -21.5% |
| LIOTON | 167 485 | -55.6% | 1.6% | -1 | 210 024 929 | -41.8% | 4.3% | -1.1 | -27.7% |
| MEZYM | 2 364 240 | -60.6% | 19.3% | -11.8 | 371 278 883 | -58.9% | 13.1% | -9.3 | -36.4% |
| MIG 400 | 1 189 145 | -49.1% | 2.3% | -1.1 | 144 627 104 | -46.4% | 1.8% | -0.9 | -25.4% |
| PROSTAMOL | 230 107 | -57.2% | 13.3% | -9.6 | 347 024 342 | -53.2% | 14.9% | -9.4 | -26.3% |
| RESPERO MYRTOL | 255 546 | -43.4% | 7.0% | -3.1 | 146 376 852 | -28.5% | 8.3% | -1.6 | -18.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 7 215 286 | -52.3% | 3.9% | -2.7 | 1 596 602 044 | -40.9% | 4.0% | -2.1 | -18.7% |
| DEXALGIN | 1 225 604 | -39.3% | 0.5% | -0.2 | 567 399 380 | -27.4% | 1.5% | -0.5 | -12.7% |
| ESPUMISAN (ADULTS) | 3 452 483 | -37.5% | 48.1% | -15.7 | 1 883 085 000 | -27.9% | 54.6% | -14.4 | -17.1% |
| ESPUMISAN BABY | 1 245 016 | -25.7% | 34.5% | -6.2 | 837 799 842 | -15.3% | 48.5% | -6.7 | -12.4% |
| FASTUM | 872 542 | -36.9% | 1.0% | -0.5 | 483 437 310 | -25.7% | 2.3% | -0.7 | -6.5% |
| IODOMARIN | 3 144 759 | -8.2% | 20.8% | -0.4 | 607 635 557 | -5.7% | 9.0% | -0.4 | -6.5% |
| LIOTON | 1 041 910 | -40.8% | 2.0% | -0.8 | 1 156 763 151 | -23.8% | 4.4% | -1.3 | -15.7% |
| MEZYM | 13 718 553 | -38.8% | 22.4% | -7.6 | 2 112 068 919 | -34.1% | 15.8% | -6.4 | -17.9% |
| MIG 400 | 7 251 052 | -31.3% | 3.0% | -0.8 | 868 768 573 | -27.4% | 2.2% | -0.8 | -12.7% |
| PROSTAMOL | 1 239 131 | -43.0% | 15.7% | -8.5 | 1 770 132 936 | -37.2% | 16.8% | -9.1 | -12.2% |
| RESPERO MYRTOL | 1 105 629 | -2.5% | 7.5% | 0.3 | 565 238 287 | 9.1% | 8.0% | 0.7 | -5.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 101 190 | -3.0% | 2.7% | -0.3 | 25 758 594 | -5.4% | 3.1% | -0.4 | 8.4% |
| DEXALGIN | 18 116 | 19.0% | 0.3% | 0 | 9 547 889 | 18.4% | 1.1% | 0 | 14.8% |
| ESPUMISAN (ADULTS) | 63 529 | 21.3% | 40.8% | -1.3 | 39 541 400 | 19.3% | 50.3% | -1 | 25.1% |
| ESPUMISAN BABY | 22 566 | 10.1% | 29.7% | 1 | 17 329 175 | 9.0% | 46.2% | 1 | 6.4% |
| FASTUM | 15 789 | 13.9% | 0.8% | 0 | 9 482 541 | 13.6% | 2.1% | -0.1 | 19.8% |
| IODOMARIN | 84 912 | 23.9% | 23.7% | 0.9 | 15 687 818 | 21.9% | 9.9% | 0.6 | 19.3% |
| LIOTON | 18 388 | 21.7% | 1.6% | 0 | 23 305 660 | 21.7% | 4.0% | 0 | 21.6% |
| MEZYM | 236 762 | 10.2% | 18.1% | -1.6 | 37 797 962 | 11.7% | 12.8% | -0.6 | 20.0% |
| MIG 400 | 133 316 | 21.2% | 2.5% | 0.1 | 15 623 973 | 21.6% | 1.8% | 0.1 | 14.8% |
| PROSTAMOL | 24 169 | 17.1% | 13.0% | 0 | 36 314 700 | 17.5% | 14.5% | 0 | 17.3% |
| RESPERO MYRTOL | 23 538 | 10.1% | 6.7% | -0.2 | 13 204 734 | 8.6% | 7.6% | -0.4 | 13.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 412 232 | -20.9% | 2.7% | -0.1 | 112 037 618 | -20.3% | 3.4% | -0.1 | -18.0% |
| DEXALGIN | 60 185 | -30.1% | 0.3% | -0.1 | 33 026 896 | -27.6% | 1.1% | -0.3 | -12.8% |
| ESPUMISAN (ADULTS) | 202 093 | -11.2% | 38.5% | -1 | 128 123 690 | -13.1% | 48.2% | -2.3 | -8.8% |
| ESPUMISAN BABY | 80 707 | -9.9% | 29.3% | -0.3 | 63 130 353 | -9.6% | 46.6% | -0.1 | -8.9% |
| FASTUM | 53 314 | -21.9% | 0.8% | -0.1 | 32 316 268 | -23.0% | 2.2% | -0.4 | -9.2% |
| IODOMARIN | 263 479 | 2.2% | 22.3% | 1.5 | 49 430 699 | 3.6% | 9.0% | 1 | -4.5% |
| LIOTON | 65 231 | 8.9% | 1.8% | 0.2 | 81 963 965 | 10.6% | 4.7% | 0.7 | -5.6% |
| MEZYM | 800 140 | -20.3% | 19.4% | -0.2 | 126 219 061 | -19.0% | 13.0% | -0.4 | -19.5% |
| MIG 400 | 394 153 | -20.0% | 2.1% | -0.2 | 46 693 631 | -25.9% | 1.6% | -0.3 | -12.8% |
| PROSTAMOL | 80 544 | -12.7% | 12.9% | -0.9 | 122 384 313 | -11.5% | 14.6% | -1 | -6.3% |
| RESPERO MYRTOL | 94 189 | -9.2% | 7.0% | -0.2 | 54 780 622 | -6.8% | 8.4% | -0.1 | -6.3% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"
## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"
## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"
## [1] "ESPUMISAN (ADULTS)"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"
## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"
## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"
## [1] "ESPUMISAN BABY"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"
## [1] "FASTUM"
## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"
## [1] "LIOTON"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"
## [1] "MEZYM"
## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS 20000 IU #20"
## [1] "MEZYM FORTE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #80"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"
## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS 10000 ED #20"
## [1] "DEXALGIN"
## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"
## [1] "MIG 400"
## [1] "MIG 400 COATED TABLETS 400 MG #10"
## [1] "MIG 400 COATED TABLETS 400 MG #20"
## [1] "PROSTAMOL"
## [1] "PROSTAMOL UNO CAPS 320 MG #30"
## [1] "PROSTAMOL UNO CAPS 320 MG #60"
## [1] "PROSTAMOL UNO CAPS 320 MG #90"
## [1] "IODOMARIN"
## [1] "IODOMARIN 100 TABS 100 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #50"
## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"
## [1] "RESPERO MYRTOL"
## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"
## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs